4th Quarter - Report
SIDLEY AUSTIN LLP for INTERCEPT PHARMACEUTICALS, INC.
Firm
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA's regulation of rare disease drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL E BORDEN | Senior Counsel, House Financial Services Committee; Counsel, House Financial Services Committee; Legislative Assistant, Office of Rep. Jim Leach |
| PATRICIA LOUISE DELOATCHE | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.